2022, Volume 15, Issue 2, pp 174 – 179

Diet, fibers, and probiotics for irritable bowel syndrome

SCImago Journal & Country Rank

Issues

Special Issues

Authors and Affiliations

*Corresponding Author: Adelina Nicoleta Galica, 2nd Department of Internal Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Nursing, Faculty of Natural and Human Sciences, Fan S. Noli University, Korçe, Albania. E-mail: adelinagalica2016@gmail.com

Abstract

Many aspects make irritable bowel syndrome (IBS) challenging for both patients and physicians. The unclear pathogenesis with many pathways to be explored, bothering symptoms that affect the quality of life, and many subtypes of the condition are only a few reasons that make IBS difficult to control and obtain satisfactory results. Treatment options start with general advice for lifestyle, continue with non-pharmaceutical treatments, and finally touch classic treatments. In this review, pharmaceutical treatment options are not accounted for. Consensus groups and meta-analyses have concluded guidelines that overall are the same, with variations in the strength of recommendations and some cultural and geographical particularities. Dietary interventions, probiotics, and fibers can be seen as non-pharmaceutical treatments that coexist in various protocols because of the relevant evidence regarding their efficacy in treating IBS symptoms.

Keywords

About this article

PMC ID: 8999090
PubMed ID: 
DOI: 10.25122/jml-2022-0028

Article Publishing Date (print): 2 2022
Available Online: 

Journal information

ISSN Printing: 1844-122X
ISSN Online: 1844-3117
Journal Title: Journal of Medicine and Life

Copyright License: Open Access

This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.


SCImago Journal & Country Rank

Issues

Special Issues